🔎 Trials Near Me

Početna › Upalna bolest crijeva › Texas

Kliničke studije za Upalna bolest crijeva u državi Texas

16 studija za Upalna bolest crijeva traži sudionike na lokacijama u državi Texas.

Gradovi u državi Texas

Službeni tekst studije (engleski)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Inquest Clinical Research, Baytown
  • DHR Health Gastroenterology - Edinburg, Edinburg
  • Baylor College of Medicine, Houston
  • i još 3
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Cedar Park
  • Xencor Investigative Site, Denton
  • Xencor Investigative Site, Garland
  • i još 8
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 013, Cedar Park
  • Site 005, Garland
  • Site 002, San Antonio
  • i još 2
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-024, Garland
  • Site US-009, Georgetown
  • Site US-030, Houston
  • i još 4
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07845487

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Cook Childrens Medical Center, Fort Worth
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT05923073

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • i još 2
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345

Study of DISC-0974-201 in Participants With IBD and Anemia

  • One of a Kind Clinical Research Center, LLC, Kingwood
  • Siena Research Network, Sugar Land
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07368972

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  • GI Alliance - Cedar Park, Cedar Park
  • North Texas Gastroenterology, Denton
  • The University of Texas Health Science Center at Houston, Houston
  • i još 3
U tijeku regrutacijaFaza 2
Od 18 do 85 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT06226883

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Cook Children's Medical Center, Fort Worth
U tijeku regrutacijaFaza 3
Od 2 do 19 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT04844606

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  • Cook Children's Medical Center, Fort Worth
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 24. kol 2026. · NCT05509777

BOOM-IBD2 Pivotal Clinical Trial

  • Amarillo Premier Research (Objective Health), Amarillo
  • Digestive Research of Central Texas (Objective Health), Waco
U tijeku regrutacija
Od 18 do 85 godina · Oba spola · Ažurirano 6. kol 2026. · NCT06571669

HB-adMSCs for the Treatment of Crohn's Disease

  • Hope Biosciences Research Foundation, Sugar Land
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 6. kol 2026. · NCT07077746

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

  • M D Anderson Cancer Center, Houston
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 20. svi 2026. · NCT04751396

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Dallas
  • Mirador Therapeutics Selected Site, Garland
  • Mirador Therapeutics Selected Site, Georgetown
  • i još 5
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 12. ožu 2026. · NCT07113522

Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease

  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 11. ožu 2026. · NCT07210580

Registry and Biorepository for IBD in Central Texas

  • Dell Medical School, UT Austin, Austin
U tijeku regrutacijaOpažajna studija
Od 18 do 100 godina · Oba spola · Ažurirano 18. svi 2021. · NCT04617184

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.